June 27, 2017 / 11:07 PM / 2 years ago

Illumina notches win in prenatal testing patent fight

A federal appeals court on Tuesday revived a patent on fetal diagnostic testing that Illumina Inc has accused rival Sequenom Inc of infringing.

The U.S. Court of Appeals for the Federal Circuit said the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board had wrongly found the patent application at issue in the case insufficient.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2tV9alF

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below